Saving Lives: Measles Initiative
- Impact
- Saving Lives: Measles Initiative
Saving Lives: Measles Initiative
IFFIm's investment in the Measles Initiative has played a key part in achieving the goal of reducing measles deaths by 90%.
IFFIm supports fight against measles
IFFIm's US$ 139 million support to The Measles Initiative, a partnership between global health and development agencies, is strengthening measles campaigns worldwide
Measles, which long-ago was sidelined as a major threat in the developed world, has been continuing to take a deathly toll in many developing nations.
It often strikes Africa, which has seen significant outbreaks in recent years, including nearly 47,000 cases in 2010 that left 731 dead.
Such loss of life is entirely preventable, yet the measles vaccine until recently was not administered routinely in western and southern Africa. Gavi, the Vaccine Alliance and its partner organisations in the Measles Inititiative have been changing that, with significant funding from IFFIm.
Liberia
Consider Liberia. In early 2011, the remote town of Zoeluapa was without electricity, sanitation and or even a health clinic. The town of 4,000 also was battling a horrendous measles outbreak, reporting five deaths from the highly infectious disease.
Doris, 10, and her sister Rhoda, 13, had it, too. "They had fever, runny eyes and sore mouths," said their mother, Dorothy Okko. She needed no convincing to take her other children to a mud and wattle hut where an emergency measles vaccination campaign was in full swing.
This programme has achieved incredible results. In short it's resulted in about 1,500 less children dying every day from measles worldwide.
Edward Hoekstra, chief of the measles programme at UNICEF
That campaign, set-up by UNICEF - one of Gavi's strategic in-country partners - was critical in containing the outbreak, which could have quickly spread not only through Liberia but to neighboring countries as well. "There are 14 children in this household, and I need help to stop them from getting sick," said Ms. Okko. "This vaccine is a blessing."
The measles vacccination campaign was rolled out by 80 teams of health workers targetting all children between 6 months and 16 years old in Nimba County, as well as handing out supplements to help prevent deaths related to measles from complications such as pneumonia and diarrhoea.
Viral respiratory infection
Measles is a viral respiratory infection that attacks the immune system.
The disease infects close to 30 million children each year and kills almost 350,000, usually from complications related to pneumonia, diarrhoea and malnutrition. Survivors of measles are often left with life-long disabilities, such as blindness, deafness or brain damage.
"These children are usually found in the most vulnerable, poorest areas in the world. Immunisation can protect millions of children against this deadly disease," said Edward Hoekstra, chief of the measles programme at UNICEF.
Outbreaks
Other recent outbreaks have occurred in Côte d'Ivoire, Ethiopia, Malawi, Mozambique, Zambia and Zimbabwe, where 400 people died of measles in May 2010.
Yet most deaths at the hands of measles are easily prevented through immunisation at a cost of less than US $1 per child.
The Measles Initiative - a collaboration of global health and development agencies, including Gavi - has vaccinated 686 million children and saved the lives of more than 4.3 million children since 1999.
IFFIm contribution
IFFIm's contribution of US$ 139 million gave the intitiative a major boost at a critical time.
"This programme has achieved incredible results. In short it's resulted in about 1,500 less children dying every day from measles worldwide," said Hoekstra.
A child smiling during the introduction of the second dose of measles vaccination in Ethiopia. Credit: Gavi/2019/Frederique Tissandier.
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.